P. Mohanakrishnan et al., REGIONAL METABOLIC ALTERATIONS IN ALZHEIMERS-DISEASE - AN IN-VITRO H-1-NMR STUDY OF THE HIPPOCAMPUS AND CEREBELLUM, The journals of gerontology. Series A, Biological sciences and medical sciences, 52(2), 1997, pp. 111-117
The concentrations of selected metabolites in the hippocampus and cere
bellum of 13 Alzheimer's diseased (AD) and four nondemented postmortem
brains were measured using high resolution H-1 NMR spectroscopy. For
both the hippocampal region and the cerebellum, the putative neuronal
marker N-acetyl aspartate (NAA) was significantly lower in AD brains r
elative to the nondemented brains. For the hippocampal region, the NAA
concentration correlated inversely with semiquantitative assessments
of neuronal loss and neurofibrillary tangles. The gamma-aminobutyric a
cid levels in both hippocampus and cerebellum of an age- and a postmor
tem interval-matched subset of AD brains were lower than those of the
controls. Because the cerebellum is generally thought to be unaffected
by AD, the NAA decrease in the Alzheimer cerebellum may be due to les
ions of either the Alzheimer or non-Alzheimer type in contralateral ce
rebrum.